Sara Browne, MD
Sara Browne, MD
Sara H. Browne, M.D. is an Associate Professor of Clinical Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego (UCSD). Dr. Browne received her undergraduate education at the University of Cape Town, RSA and her medical degree from the Oxford University School of Medicine. She has a master of public health from the Harvard University School of Public Health, where she was a Fulbright Scholar. She completed her license in the United Kingdom at the John Radcliffe Hospital, Oxford, UK. She did her residency in Internal Medicine at Stanford University Medical Center, where subsequently completed a Clinical Pharmacology Fellowship at Stanford University and an Infectious Diseases Fellowship at UCSD.
Since joining the UCSD faculty in 2006, Dr. Browne’s main focus has been Global Health and more recently Mobile Health. She has partnered with 3 institutions in South Africa (Stellenbosch University in the Western Cape and Rhodes University, Walter Sisulu University in the Eastern Cape) to support the development of skilled medically trained research faculty locally, to better address clinical research questions crucial to the combat and treatment of the HIV/TB epidemics in Southern Africa. She has successfully mentored South African medical faculty in the design and development of three NIH-funded international HIV research projects in the areas of ART adherence, metabolic side effects in ART and transmitted HIV resistance. Research from these partnerships continues to yield both vital clinical data and clinical tools to implement in the field.
Dr. Browne currently conducts translational research and clinical trials to analyze and support patient medication adherence and promote medication literacy in the treatment of HIV/AIDS, TB, and chronic diseases. She seeks to provide new paradigms of healthcare delivery especially in the arena of patient self-management with the use of novel mobile health (mHealth) technologies. In collaboration with Proteus Digital Health, who have developed an ingestible event marker that is able to capture oral ingestion medication, Dr. Browne is investigating the efficacy of mHealth sensor technology to monitor treatment of Mycobacterium tuberculosis. She is an Alliance Healthcare Foundation Innovation Award recipient for this work.
Dr. Browne also has a strong background in laboratory-based research, she has performed work on signal transduction in neurobiology and in microbial genomics. She continues to collaborate with the bacterial pathogenesis group led by Dr. Don Guiney and an HIV Malignancy Group led by Dr. Davey Smith.
- Browne SH. Editorial commentary: dialing for doses: enhancing community-based adherence support with mobile technologies. Clin Infect Dis. 2013 May;56(9):1327-9. Epub 2012 Dec 18. PubMed PMID:23249610
- Innes S, Schulte-Kemna E, Cotton MF, Zöllner EW, Haubrich R, Klinker H, Sun X, Jain S, Edson C, van Niekerk M, Innes ER, Rabie H, Browne SH. Biceps Skin-Fold Thickness May Detect and Predict Early Lipoatrophy in HIV-Infected Children. Pediatr Infect Dis J. 2012 Dec 17. [Epub ahead of print] PubMed PMID: 23249919.
- Innes S, Cotton MF, Haubrich R, Conradie MM, van Niekerk M, Edson C, Rabie H, Jain S, Sun X, Zöllner EW, Hough S, Browne SH. High prevalence of lipoatrophy in pre-pubertal South Africanchildren on antiretroviral therapy: a cross-sectional study. BMC Pediatr. 2012 Nov 23;12:183. PubMed PMID: 23176441; PubMed Central PMCID: PMC3584923.
- Preziosi MJ, Kandel SM, Guiney DG, Browne SH. Microbiological analysis of non-typhoidal Salmonella strains causing distinct syndromes of bacteremia or enteritis in HIV/AIDS patients in San Diego,California. J Clin Microbiol. 2012 Nov;50(11):3598-603. Epub 2012 Aug 29. PubMed PMID:22933605; PubMed Central PMCID: PMC3486235.
- R.Dowse, T.Ramela, K-L. Barford, S.H.Browne. An illustrated leaflet containing antiretroviral information targeted for low-literate readers: Development and Evaluation. Patient Education and Counseling Patient Educ Couns., 2011 Feb 7.